Market Trends

As usual, Warren Buffett said it best.

Small-cap investors have been disappointed for years. Here's why that trend might finally be ready to reverse.

The S&P 500 is trading at record levels, and for investors, tracking the total stock market may be more appealing right now -- but that doesn't mean it's a sound strategy.

Consistency matters more than ultra-high yields.

Market indicators are warning about volatility, but history has good news for investors.

This Vanguard ETF wins on costs, while the iShares delivered stronger 12-month returns.

XBI's lower fees and 155-stock portfolio contrast sharply with FBT's concentrated 30-holding approach, though FBT has experienced less volatility over the past five years.

Cerebras unveils faster AI chip, OpenAI's losses widen, and more...

One offers concentrated exposure to 29 pharma giants with lower volatility, while the other provides broader diversification across 251 biotech companies at a cheaper cost.

History has good and bad news for investors right now.

The stock market has historically rewarded investors who buy the dip during corrections.

Berkshire's bosses have been net sellers of stocks in 14 of the last 15 quarters.

Kevin Warsh is sticking to his guns, and that could mean vastly more uncertainty for some companies.

XOP targets upstream drillers with a 0.35% expense ratio and 46.4% 1-year returns, while EMLP focuses on pipelines and utilities with a 2.8% dividend yield but deeper volatility.

XOP's 0.35% expense ratio and lower volatility appeal to conservative investors, while TAN's 1.41 beta offers higher conviction exposure to renewable energy.

SGDM delivered stronger five-year returns despite trailing SIL over the past year, while maintaining a lower expense ratio and less volatility.

MGK offers lower costs and mega-cap stability; SLYG delivered 27.4% returns over one year with broader diversification across industrials and healthcare.

The top S&P 500 ETF is still a reliable investment for patient investors.

Vanguard offers lower fees and $69.9B in assets, while iShares delivers a higher 4.3% dividend yield. Which suits your income strategy?

The Schwab U.S. Dividend Equity ETF provides investors with a high yield and exposure to many top dividend stocks.